Cargando…
Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852543/ https://www.ncbi.nlm.nih.gov/pubmed/32999471 http://dx.doi.org/10.1038/s41416-020-01103-0 |
| _version_ | 1783645841979867136 |
|---|---|
| author | Oliver, Thomas Richard William Jackson, Thomas John Ogunbiyi, Olumide Sebire, Neil Slater, Olga Jorgensen, Mette Behjati, Sam |
| author_facet | Oliver, Thomas Richard William Jackson, Thomas John Ogunbiyi, Olumide Sebire, Neil Slater, Olga Jorgensen, Mette Behjati, Sam |
| author_sort | Oliver, Thomas Richard William |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7852543 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78525432021-02-08 Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 Oliver, Thomas Richard William Jackson, Thomas John Ogunbiyi, Olumide Sebire, Neil Slater, Olga Jorgensen, Mette Behjati, Sam Br J Cancer Correspondence Nature Publishing Group UK 2020-10-01 2021-01-19 /pmc/articles/PMC7852543/ /pubmed/32999471 http://dx.doi.org/10.1038/s41416-020-01103-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Oliver, Thomas Richard William Jackson, Thomas John Ogunbiyi, Olumide Sebire, Neil Slater, Olga Jorgensen, Mette Behjati, Sam Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title | Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title_full | Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title_fullStr | Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title_full_unstemmed | Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title_short | Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020 |
| title_sort | comment on: “tumour-agnostic drugs in paediatric cancers”, chisholm et al., bjc 2020 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852543/ https://www.ncbi.nlm.nih.gov/pubmed/32999471 http://dx.doi.org/10.1038/s41416-020-01103-0 |
| work_keys_str_mv | AT oliverthomasrichardwilliam commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT jacksonthomasjohn commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT ogunbiyiolumide commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT sebireneil commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT slaterolga commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT jorgensenmette commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 AT behjatisam commentontumouragnosticdrugsinpaediatriccancerschisholmetalbjc2020 |